The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV
Part of paid clinical trials in Marietta, Georgia.
- Sponsor
- Tyson Perez, DC, PhD
- Study ID
- NCT07466836
- Status
- Recruiting
Conditions
- Human Immunodeficiency Virus (HIV)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Chiropractic Care — PROCEDUREFull-spine Chiropractic Care
Study Details
The main aim of this pilot trial is to investigate the feasibility of undertaking a randomized controlled trial involving adults living with HIV. Additionally, this trial will explore potential change differences in self-reported quality of life and blood-derived immune markers between a chiropractic care group and no treatment controls.
Key Dates
- Start date
- Apr 11, 2026
- Status verified
- May 2026
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ChiropracticParticipants in this arm will continue their physician-prescribed anti-retroviral therapy (ART) as per standard of care and will receive once per week chiropractic care during the 6-month trial period.
- No Intervention: ControlsParticipants in this arm will continue their physician-prescribed anti-retroviral therapy (ART) as per standard of care but will not receive chiropractic care during the 6-month trial period.
Primary Outcome Measure
Proportion of eligible individuals enrolled [ Time Frame: From online screen submission to enrollment (up to 2 weeks). ]
Central Contacts
- Research Programs & Grants Administrator678-331-4527
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Life University | Marietta | Georgia | 30060 | Christie Kwon, MS, DC, MPH Tyson Perez, DC, PhD (SUB_INVESTIGATOR) |
Find similar trials in Marietta, GA
By research site
Related Studies
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Birmingham, Alabama
- C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United StatesNot Yet Recruiting · UNC Lineberger Comprehensive Cancer Center · Atlanta, Georgia
- Persuasive Health Communication Intervention for HIV/HCVRecruiting · University of South Florida · New York, New York
- Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical CarePHASE4 · Recruiting · New York University · New York, New York